Resurgent methamphetamine use at treatment admission in the United States, 2008-2017

American Journal of Public Health

Volumn 110, Issue 4, 2020, Pages 509-516

  Jones, Christopher M ^a   Olsen, Emily O ^a   O'Donnell, Julie ^a   Mustaquim, Desiree ^a  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHAMPHETAMINE;

ADOLESCENT; ADULT; CHILD; DRUG DEPENDENCE; FEMALE; HOSPITALIZATION; HUMAN; INJECTION; MALE; MIDDLE AGED; UNITED STATES;

ADOLESCENT; ADULT; CHILD; FEMALE; HEROIN; HOSPITALIZATION; HUMANS; INJECTIONS; MALE; METHAMPHETAMINE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85081945008     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2019.305527     Document Type: Review

References (35)

1. Barr AM, Panenka WJ, MacEwan GW, et al. The need for speed: An update on methamphetamine addiction. J Psychiatry Neurosci. 2006; 31(5):301-313.
2. Voce A, Calabria B, Burns R, Castle D, McKetin R. A systematic review of the symptom profile and course of methamphetamine-associated psychosis. Subst Use Misuse. 2019; 54(4):549-559.
3. Prakash MD, Tangalakis K, Antonipillai J, Stajanovska L, Nurgali K, Apostolopoulos V. Methamphetamine: Effects on the brain, gut and immune system. Pharmacol Res. 2017; 120:60-67.
4. Wang TY, Fan TT, Bao YP, et al. Pattern and related factors of cognitive impairment among chronic methamphetamine users. Am J Addict. 2017; 26(2):145-151.
5. Darke S, Duflou J, Kaye S. Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study. Drug Alcohol Depend. 2017; 179:174-179.
6. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs. 2010; 42(1): 11-18.
7. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: Current trends and implications for interventions. Curr HIV/AIDS Rep. 2010; 7(2):99-106.
8. Cunningham EB, Jacka B, DeBeck K, et al. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among streetinvolved youth inVancouver, Canada. Drug AlcoholDepend. 2015; 152:272-276.
9. Darke S, Kaye S, Duflou J. Rates, characteristics and circumstances of methamphetamine-related death in Australia: A national 7-year study. Addiction. 2017; 112(12): 2191-2201.
10. Degenhardt L, Sara G, McKetin R, et al. Crystalline methamphetamine use and methamphetamine-related harms inAustralia. Drug Alcohol Rev. 2017; 36(2):160-170.
11. Leslie EM, Smirnov A, Cherney A, et al. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users. Addict Behav. 2017; 70:27-34.
12. Uhlmann S, DeBeck K, Simo A, Kerr T, Montaner JS, Wood E. Health and social harms associated with crystalmethamphetamine use among street-involved youth in a Canadian setting. Am J Addict. 2014; 23(4):393-398.
13. Drug Enforcement Administration. National drug threat assessment, 2018. Available at: Https://www. dea.gov/sites/default/files/2018-11/DIR-032-18% 202018%20NDTA%20final%20low%20resolution.pdf. Accessed October 2, 2019.
14. Drug Enforcement Administration.NFLIS-drug special report: Methamphetamine reported in NFLIS, 2001-2017. 2019. Available at: Https://www.nflis.deadiversion.usdoj. gov/DesktopModules/ReportDownloads/Reports/12568NFLISdrugMethamphetamine.pdf. Accessed September 30, 2019.
15. US Customs and Border Protection. CBP Enforcement Statistics FY 2019. Available at: Https://www. cbp.gov/newsroom/stats/cbp-enforcement-statistics. Accessed October 2, 2019.
16. Glatter R. In shadow of opioid crisis, methamphetamine use rising in US. Forbes. 2018. Available at: Https://www.forbes.com/sites/robertglatter/2018/10/29/inshadow-of-opioid-crisis-methamphetamine-use-risingin-u-s/#5c9882044a06. Accessed October 1, 2019.
17. Dembosky A. As meth use surges, first responders struggle to help those in crisis. National Public Radio. Available at: Https://www.npr.org/sections/healthshots/2019/05/01/716404677/as-meth-use-surgesfirst-responders-struggle-to-help-those-in-crisis. Accessed October 2, 2019.
18. Substance Abuse and Mental Health Services Administration. 2017 National Survey on Drug Use and Health. Detailed tables. 2018. Available at: Https://www. samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017. pdf. Accessed September 30, 2019.
19. Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential-United States, 2003-2017. MMWR Morb Mortal Wkly Rep. 2019; 68(17):388-395.
20. Glick SN, Burt R, Kummer K, Tinsley J, Banta-Green CJ, Golden MR. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug AlcoholDepend. 2018; 182:86-92.
21. Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin andmethamphetamine injection: Anemerging drug use pattern. Subst Use Misuse. 2017; 52(8):1051-1058.
22. Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018; 193:14-20.
23. Jones CM. Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the US. Int J Drug Policy. 2019; 70:22-32.
24. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) public use files. 2019. Available at: Https://wwwdasis.samhsa. gov/dasis2/teds.htm. Accessed September 7, 2019.
25. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-351.
26. Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17. Addiction. 2019; Epub ahead of print.
27. O'Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by Census region-United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017; 66(34):897-903.
28. Hser YI, Evans E, Huang YC. Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28(1):77-85.
29. Mayo LM, Paul E, DeArcangelis J, Van Hedger K, de Wit H. Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans. Psychopharmacology (Berl). 2019; 236(8):2413-2423.
30. Maxwell JC. A new survey of methamphetamine users in treatment: who they are, why they like "meth" and why they need additional services. Subst Use Misuse. 2014; 49(6):639-644.
31. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: A review. Am J Drug Alcohol Abuse. 2003; 29(1):19-53.
32. Spoth R, Redmond C, Shin C, Greenberg M, Feinberg M, Trudeau L. PROSPER delivery of universal preventive interventions with young adolescents: Longterm effects on emerging adult substance misuse and associated risk behaviors. Psychol Med. 2017; 47(13): 2246-2259.
33. Flynn KC, Hoffer LD. Transitioning illicit drug preferences and emerging user identifies in Ohio: The proliferation of methamphetamine use among African Americans. J Ethn Subst Abuse. 2019; 18(1):67-88.
34. Rawson RA, Gonzales R, Marinelli-Casey P, Ang A. Methamphetamine dependence: A closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am J Addict. 2007; 16(4):291-299.
35. De Crescenzo F, Ciabattini M, D'Alo GL, et al. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network metaanalysis. PLoS Med. 2018; 15(12):e1002715